Aspira Women's Health files 8-K for Q2 2023 earnings; exhibit not provided

Aspira Women's Health Inc.

2023-Q2 EPS reported -$1.00 revenue$4,807,000

Issued press release on August 14, 2023, reporting financial results for Q2 2023.
Specific financial data (revenue, EPS) not included in this summary.
Full press release is attached as Exhibit 99.1 but text was not provided.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.7

Aspira Women's Health Inc. reported financial results for the three and six months ended June 30, 2023.

Period: the three and six months ended June 30, 2023
Result: reported results

Exact text from the filing

On August 14, 2023, Aspira Women’s Health Inc. (the “Company”) issued a press release reporting financial results for the three and six months ended June 30, 2023.

View on SEC.gov

13 earnings releases filed in the last 30 days. Browse all earnings releases →

Aspira Women's Health Inc. filing history →

Source: SEC EDGAR

accession 0000926617-23-000068

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.